Arcturus Therapeutics Holdings Inc. (ARCT) Return On Equity % [USD] 2019 - 2024

Historical data

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Arcturus Therapeutics Holdings Inc. quarterly/annual Return On Equity history and growth rate from 2019 to 2024.
  • Arcturus Therapeutics Holdings Inc. Return On Equity for the quarter ending March 31, 2024 was -38.7 %, a 180% decline year-over-year.
  • Arcturus Therapeutics Holdings Inc. annual Return On Equity for 2023 was -10.1 %, a 309% decline from 2022.
  • Arcturus Therapeutics Holdings Inc. annual Return On Equity for 2022 was 4.85 %.
  • Arcturus Therapeutics Holdings Inc. annual Return On Equity for 2021 was -71.1 %, a 89.4% decline from 2020.
Return On Equity, Quarterly (% [USD])
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2024 -38.7 -87.3 -180% Jan 1, 2024 Mar 31, 2024
Q4 2023 -10.1 -15 -309% Oct 1, 2023 Dec 31, 2023
Q3 2023 34.1 +115 Jul 1, 2023 Sep 30, 2023
Q2 2023 31.2 +110 Apr 1, 2023 Jun 30, 2023
Q1 2023 48.6 +130 Jan 1, 2023 Mar 31, 2023
Q4 2022 4.85 +76 Oct 1, 2022 Dec 31, 2022
Q3 2022 -80.4 -20.7 -34.7% Jul 1, 2022 Sep 30, 2022
Q2 2022 -78.5 -29 -58.5% Apr 1, 2022 Jun 30, 2022
Q1 2022 -81.2 -38.2 -88.8% Jan 1, 2022 Mar 31, 2022
Q4 2021 -71.1 -33.6 -89.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 -59.7 -7.39 -14.1% Jul 1, 2021 Sep 30, 2021
Q2 2021 -49.5 +39.9 +44.6% Apr 1, 2021 Jun 30, 2021
Q1 2021 -43 +72.2 +62.7% Jan 1, 2021 Mar 31, 2021
Q4 2020 -37.6 +78.4 +67.6% Oct 1, 2020 Dec 31, 2020
Q3 2020 -52.3 Jul 1, 2020 Sep 30, 2020
Q2 2020 -89.4 Apr 1, 2020 Jun 30, 2020
Q1 2020 -115 Jan 1, 2020 Mar 31, 2020
Q4 2019 -116 Oct 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.